Autologous anti-GD2 CAR T cells efficiently target primary human glioblastoma

被引：0

作者：

Chiara Chiavelli

Malvina Prapa

Giulia Rovesti

Marco Silingardi

Giovanni Neri

Giuseppe Pugliese

Lucia Trudu

Massimiliano Dall’Ora

Giulia Golinelli

Giulia Grisendi

Jonathan Vinet

Marco Bestagno

Carlotta Spano

Roberto Vito Papapietro

Roberta Depenni

Katia Di Emidio

Anna Pasetto

Daniela Nascimento Silva

Alberto Feletti

Silvia Berlucchi

Corrado Iaccarino

Giacomo Pavesi

Massimo Dominici

机构：

[1] University of Modena and Reggio Emilia,Laboratory of Cellular Therapy, Division of Oncology, Department of Medical and Surgical Sciences for Children & Adults

[2] University of Modena and Reggio Emilia,Clinical and Experimental Medicine PhD Program

[3] University-Hospital of Modena and Reggio Emilia,Department of Oncology and Hematology

[4] Great Maze Pond,Leucid Bio Ltd., Guy’s Hospital

[5] Evotec (Modena) Srl,Center for Cellular Immunotherapies

[6] Medolla,Centro Interdipartimentale Grandi Strumenti (CIGS)

[7] Perelman School of Medicine,Department of Biomedical, Metabolic and Neural Sciences

[8] and Parker Institute for Cancer Immunotherapy at University of Pennsylvania,Section for Cell Therapy, Radiumhospitalet

[9] University of Modena and Reggio Emilia,Department of Laboratory Medicine

[10] International Centre for Genetic Engineering and Biotechnology,Department of Neurosciences, Biomedicine and Movement Sciences, Neurosurgery Unit

[11] University of Modena and Reggio Emilia,Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia

[12] Oslo University Hospital, Division of Neurosurgery, Department of Neurosciences

[13] Karolinska Institutet,undefined

[14] University of Verona,undefined

[15] University-Hospital of Modena and Reggio Emilia,undefined

来源：

npj Precision Oncology | / 8卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Glioblastoma (GBM) remains a deadly tumor. Treatment with chemo-radiotherapy and corticosteroids is known to impair the functionality of lymphocytes, potentially compromising the development of autologous CAR T cell therapies. We here generated pre-clinical investigations of autologous anti-GD2 CAR T cells tested against 2D and 3D models of GBM primary cells. We detected a robust antitumor effect, highlighting the feasibility of developing an autologous anti-GD2 CAR T cell-based therapy for GBM patients.

引用

共 50 条

[1] AUTOLOGOUS ANTI-GD2 CAR T CELLS EFFICIENTLY TARGET PRIMARY HUMAN GLIOBLASTOMA
Chiavelli, C.
Prapa, M.
Neri, G.
Pugliese, G.
Rovesti, G.
Trudu, L.
Grisendi, G.
dall'ora, M.
Golinelli, G.
Bestagno, M.
Candini, O.
Spano, C.
Di Tinco, R.
Bertoni, L.
Carnevale, G.
Papapietro, R.
Depenni, R.
Feletti, A.
Iaccarino, C.
Pavesi, G.
Dominici, M.
CYTOTHERAPY, 2022, 24 (05) : S130 - S131
[2] Autologous anti-GD2 CAR T cells efficiently target primary human glioblastoma
Chiavelli, Chiara
Prapa, Malvina
Rovesti, Giulia
Silingardi, Marco
Neri, Giovanni
Pugliese, Giuseppe
Trudu, Lucia
Dall'Ora, Massimiliano
Golinelli, Giulia
Grisendi, Giulia
Vinet, Jonathan
Bestagno, Marco
Spano, Carlotta
Papapietro, Roberto Vito
Depenni, Roberta
Di Emidio, Katia
Pasetto, Anna
Nascimento Silva, Daniela
Feletti, Alberto
Berlucchi, Silvia
Iaccarino, Corrado
Pavesi, Giacomo
Dominici, Massimo
NPJ PRECISION ONCOLOGY, 2024, 8 (01)
[3] AUTOLOGOUS ANTI-GD2 CAR-T CELLS EFFICIENTLY TARGET PRIMARY HUMAN GLIOBLASTOMA
Chiavelli, C.
Rovesti, G.
Prapa, M.
Neri, G.
Pugliese, G.
Trudu, L.
Silingardi, M.
Dall'Ora, M.
Golinelli, G.
Grisendi, G.
Bestagno, M.
Spano, C.
Papapietro, R. V.
Depenni, R.
Di Emidio, K.
Pasetto, A.
Silva, D. Nascimento
Feletti, A.
Berlucchi, S.
Iaccarino, C.
Pavesi, G.
Dominici, M.
HUMAN GENE THERAPY, 2023, 34 (21-22) : A42 - A43
[4] ANTI-GD2 CAR T CELLS AGAINST SMALL CELL LUNG CANCER
Neri, G.
Chiavelli, C.
Trudu, L.
Prapa, M.
Golinelli, G.
Pugliese, G.
Silingardi, M.
Rovesti, G.
Grisendi, G.
Bestagno, M.
Spano, C.
Benati, D.
Recchia, A.
Masciale, V.
Bertolini, F.
Dominici, M.
CYTOTHERAPY, 2023, 25 (06) : S243 - S244
[5] GD2 CAR T cells against human glioblastoma
Prapa, Malvina
Chiavelli, Chiara
Golinelli, Giulia
Grisendi, Giulia
Bestagno, Marco
Di Tinco, Rosanna
Dall'Ora, Massimiliano
Neri, Giovanni
Candini, Olivia
Spano, Carlotta
Petrachi, Tiziana
Bertoni, Laura
Carnevale, Gianluca
Pugliese, Giuseppe
Depenni, Roberta
Feletti, Alberto
Iaccarino, Corrado
Pavesi, Giacomo
Dominici, Massimo
NPJ PRECISION ONCOLOGY, 2021, 5 (01)
[6] GD2 CAR T cells against human glioblastoma
Malvina Prapa
Chiara Chiavelli
Giulia Golinelli
Giulia Grisendi
Marco Bestagno
Rosanna Di Tinco
Massimiliano Dall’Ora
Giovanni Neri
Olivia Candini
Carlotta Spano
Tiziana Petrachi
Laura Bertoni
Gianluca Carnevale
Giuseppe Pugliese
Roberta Depenni
Alberto Feletti
Corrado Iaccarino
Giacomo Pavesi
Massimo Dominici
npj Precision Oncology, 5
[7] DEVELOPMENT AND CHARACTERIZATION OF NOVEL ANTI-GD2 TARGET MODULES FOR RETARGETING OF UNIVERSAL CAR T CELLS TOWARD GD2 EXPRESSING TUMORS
Mitwasi, N.
Feldmann, A.
Bergmann, R.
Berndt, N.
Roessig, C.
Bachmann, M.
HUMAN GENE THERAPY, 2018, 29 (11) : A9 - A9
[8] TARGETING GLIOBLASTOMA & DIFFUSE INTRINSIC PONTINE GLIOMA W/ANTI-GD2 CAR MODIFIED NK CELLS
Aggarwal, Payal
Luo, Wen
Pehlivan, Katherine
Hoang, Hai
Cairo, Mitchell
PEDIATRIC BLOOD & CANCER, 2023, 70 : S5 - S6
[9] Novel anti-GD2 CAR-T cells exhibit superior cytotoxicity against neuroblastoma
Ji, Cheng
You, Fengtao
Zhang, Tingting
Fan, Shuangshuang
Han, Zhichao
Xiang, Shufen
Wang, Yinyan
Sheng, Binjie
Wang, Tian
An, Gangli
Meng, Huimin
Yang, Lin
EUROPEAN JOURNAL OF INFLAMMATION, 2020, 18
[10] Generation of anti-GD2 CAR macrophages from human pluripotent stem cells for cancer immunotherapies
Zhang, Jue
Webster, Sarah
Duffin, Bret
Bernstein, Matthew N.
Steill, John
Swanson, Scott
Forsberg, Matthew H.
Bolin, Jennifer
Brown, Matthew E.
Majumder, Aditi
Capitini, Christian M.
Stewart, Ron
Thomson, James A.
Slukvin, Igor I.
STEM CELL REPORTS, 2023, 18 (02): : 585 - 596

← 1 2 3 4 5 →